Product Reviews
Categories
- Alternative Medicine
- Cancer
- Acute Promyelocytic Leukemia
- Anal Cancer
- Bladder Cancer
- Breast cancer
- Colorectal cancer
- Endometrial Cancer
- Esophageal Cancer
- Gallbladder cancer
- Gastric Cancer
- Glioblastma
- Head and Neck Cancer
- Liver Cancer
- Lung Cancer
- Lymphoma
- Melanoma
- Nasopharyngeal Cancer
- Non-Hodgkin's Disease
- Ovarian Cancer
- Pancreatic Cancer
- Prostate cancer
- Renal Cancer
- Thyroid Cancer
- Cardiovascular disease
- Central Nervous System
- Constipation
- Diabetes
- Fatty Liver
- Irritable Bowel Syndrome
- Longevity
- Motherhood
- Obesity
- Others
- Psoriasis
- Respiratory Disease
- Rheumatoid Arthritis
Archives
Tag Archives: Survival
Everolimus (Affinitor) Improves Survival in Pancreatic Neuroendocrine Tumors
Pancreatic neuroendocrine tumors affect the hormone-producing tissues within the pancreas, and have an incidence rate, affecting only 2 to 4 people per million worldwide. The incidence, however, is rising, and has quadrupled in the past 30 years, according to data … Continue reading
Posted in Cancer, Pancreatic Cancer
Tagged Affinitor, anthracyclines, Everolimus, fluoropyrimidines, Neuroendocrine tumor, octreotide, Pancreatic Cancer, Sandostatin, streptozocin, sunitinib, Survival, Sutent, Zanosar
Comments Off on Everolimus (Affinitor) Improves Survival in Pancreatic Neuroendocrine Tumors
Gefitinib (Iressa) is better than Standard Therapy in Lung Cancer with EGFR Mutations
Gefitinib (Iressa) is more effective than first-line therapy in improving survival without disease in patients with advanced nonsmall-cell lung cancer (NSCLC) and epidermal growth-factor receptor (EGFR) mutations. The current study was conducted in 230 patients from 43 centers in Japan, … Continue reading
Posted in Lung Cancer, Non Small Cell Lung Cancer
Tagged carboplatin, EGFR, epidermal growth-factor receptor, gefitinib, Iressa, Lung Cancer, mutations, Non small cell lung cancer, paclitaxel, Survival
Comments Off on Gefitinib (Iressa) is better than Standard Therapy in Lung Cancer with EGFR Mutations
Efficacy and tolerability of Avastin plus Xeloda as first-line therapy in patients with advanced Liver Cancer
Liver cancer is the fifth most common cancer worldwide and the third most common cause of cancer mortality. More than 80% of cases occur in East Asia and sub-Sharan Africa, and the incidence is increasing in Europe and the US. … Continue reading
Posted in Cancer, Liver Cancer
Tagged Avastin, bevacizumab, capecitabine, Liver cancer, Nexavar, sorafenib, Survival, Xeloda
Comments Off on Efficacy and tolerability of Avastin plus Xeloda as first-line therapy in patients with advanced Liver Cancer
New Chemotherapy, Cabazitaxel (Jevtana), for Advanced Prostate Cancer
A new chemotherapy, Cabazitaxel (Jevtana) has been approved in the United States to treat men who have advanced hormone-refractory prostate cancer and have failed docetaxel. The approval was based on the results of the phase 3 TROPIC clinical study, which … Continue reading
Posted in Cancer, Prostate cancer
Tagged cabazitaxel, chemotherapy, hormone refractory, Jevtana, mitoxantrone, Prostate cancer, Survival, TROPIC
Comments Off on New Chemotherapy, Cabazitaxel (Jevtana), for Advanced Prostate Cancer
Is Shark Cartilage Helpful For Cancer Patients?
Shark cartilage has been touted as a potential alternative or complementary cancer treatment for several decades. Dozens of shark cartilage products are sold as dietary supplements, but none have been studied in humans. A recently published study indicated that adding a … Continue reading
Posted in Cancer, Lung Cancer, Non Small Cell Lung Cancer, Tea
Tagged Cancer, curcumin, Green Tea, Non small cell lung cancer, NSCLC, Shark Cartilage, Survival
Comments Off on Is Shark Cartilage Helpful For Cancer Patients?
Avastin Boosts Progression-Free Survival in Ovarian Cancer Patients
Adding bevacizumab (Avastin) to chemotherapy, followed by bevacizumab as maintenance therapy, can significantly prolong progression-free survival in women with advanced ovarian cancer. The study consisted of 1873 women with newly diagnosed stage III (macroscopic residual disease) or stage IV ovarian, primary peritoneal, … Continue reading
Posted in Cancer, Ovarian Cancer
Tagged Avastin, bevacizumab, carboplatin, maintenance therapy, Ovarian Cancer, paclitaxel, Survival
Comments Off on Avastin Boosts Progression-Free Survival in Ovarian Cancer Patients
Ipilimumab – new option for Metastatic Melanoma patients
At ASCO this past weekend, Dr. Steven O’Day reported that ipilimumab alone or in combination with vaccine increased overall survival (OS) in patients with unresectable stage III/IV melanoma for whom previous treatment had failed (Abstract 4). Metastatic (stage IV) melanoma is very … Continue reading
Posted in Cancer, Melanoma
Tagged chemotherapy, Ipilimumab, Melanoma, Stage IV melanoma, Survival
Comments Off on Ipilimumab – new option for Metastatic Melanoma patients
Standard Chemo Better Than Oral Capecitabine in Elderly Breast Cancer
Most elderly breast cancer patients would prefer oral chemotherapy such as capecitabine (Xeloda, Roche) over intravenous chemotherapy due to the convenience. However, a clinical trial conducted in elderly women with early-stage breast cancer has found that standard adjuvant combination chemotherapy … Continue reading
Posted in Breast cancer, Cancer
Tagged 5-Fluorouracil, 5-FU, Breast cancer, capecitabine, chemotherapy, Cyclophosphamide, doxorubicin, Methotrexate, Survival, Xeloda
Comments Off on Standard Chemo Better Than Oral Capecitabine in Elderly Breast Cancer
New treatment modality (Yttrium-90 Microspheres) Improves Survival in Patients With Liver Cancer
Each year, there are about 18,500 cases of primary liver cancer diagnosed and the most common form is hepatocellular carcinoma. However, more than 75% of hepatocellular carcinoma patients can not have surgery to remove their liver tumors and chemotherapy and … Continue reading
Posted in Cancer, Liver Cancer
Tagged chemotherapy, Cure, Hepatocellular carcinoma, Liver cancer, Microspheres, Radiation, Shrinkage, Survival, TheraSphere, Yittrium-90
Comments Off on New treatment modality (Yttrium-90 Microspheres) Improves Survival in Patients With Liver Cancer
